These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8427752)

  • 21. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
    Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y
    Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media.
    Saeed M; Wendland MF; Masui T; Higgins CB
    Magn Reson Med; 1994 Jan; 31(1):31-9. PubMed ID: 8121266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial infarction: assessment with an intravascular MR contrast medium. Work in progress.
    Saeed M; Wendland MF; Masui T; Connolly AJ; Derugin N; Brasch RC; Higgins CB
    Radiology; 1991 Jul; 180(1):153-60. PubMed ID: 2052685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images.
    van Dijkman PR; van der Wall EE; de Roos A; Matheijssen NA; van Rossum AC; Doornbos J; van der Laarse A; van Voorthuisen AE; Bruschke AV
    Radiology; 1991 Jul; 180(1):147-51. PubMed ID: 2052683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of perfusion in myocardial viability studies using delayed contrast-enhanced magnetic resonance imaging.
    Hedström E; Arheden H; Eriksson R; Johansson L; Ahlstrom H; Bjerner T
    J Magn Reson Imaging; 2006 Jul; 24(1):77-83. PubMed ID: 16755547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling.
    Watzinger N; Lund GK; Higgins CB; Wendland MF; Weinmann HJ; Saeed M
    J Magn Reson Imaging; 2002 Dec; 16(6):633-40. PubMed ID: 12451576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction.
    Yu KK; Saeed M; Wendland MF; Dae MW; Velasquez-Rocha S; Derugin N; Higgins CB
    Invest Radiol; 1993 Nov; 28(11):1015-23. PubMed ID: 7506243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ischemic myocardial viability assessment with interleaved T1-T2* magnetic resonance imaging].
    Li G; Tian WC; Ji YN; Li SM; Yu B; Tian GH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):536-40. PubMed ID: 19100069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delineation of acute myocardial infarction with dysprosium DTPA-BMA: influence of dose of magnetic susceptibility contrast medium.
    Saeed M; Wendland MF; Yu KK; Higgins CB
    J Am Coll Cardiol; 1992 Dec; 20(7):1634-41. PubMed ID: 1452938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adrenal myelolipomas: their magnetic resonance assessment].
    Boraschi P; Braccini G; Gigoni R; Cartei F; Campatelli A; Di Vito A; Perri G
    Clin Ter; 1996 Nov; 147(11):549-57. PubMed ID: 9264908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium.
    Saeed M; Wendland MF; Takehara Y; Masui T; Higgins CB
    Radiology; 1992 Mar; 182(3):675-83. PubMed ID: 1535880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Area at risk and viability after myocardial ischemia and reperfusion can be determined by contrast-enhanced cardiac magnetic resonance imaging.
    Vosseler M; Abegunewardene N; Hoffmann N; Petersen SE; Becker D; Cleppien D; Kunz P; Kreitner KF; Lauterbach M; Bierbach B; Düber C; Gori T; Munzel T; Schreiber LM; Horstick G
    Eur Surg Res; 2009; 43(1):13-23. PubMed ID: 19365131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of chronic myocardial infarction with extracellular or intravascular contrast agents in magnetic resonance imaging.
    Wang J; Liu HY; Lv H; Xiang B; Gruwel M; Tomanek B; Deslauriers R; Tian GH
    Acta Pharmacol Sin; 2008 Jan; 29(1):65-73. PubMed ID: 18158867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial "low reflow" assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model.
    Arteaga C; Revel D; Zhao S; Hadour G; Forrat R; Oksendal A; Canet E
    J Magn Reson Imaging; 1999 May; 9(5):679-84. PubMed ID: 10331763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
    Schnorr J; Wagner S; Ebert W; Heyer C; Laub G; Kivelitz D; Abramjuk C; Hamm B; Taupitz M
    Rofo; 2003 Jun; 175(6):822-9. PubMed ID: 12811696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.